Australia has hosted several innovations in the 3D printed medical device industry, however widespread adoption and diffusion is quite low. This two-year project funded by the RMIT ECP Opportunity Fund (EOF) provides analysis of the industry, its stakeholders (i.e. surgeons, patients, small and large manufacturers, insurers, researchers and regulatory bodies), the barriers it faces and proposes potential solutions.
This project resulted in two white papers. The first white paper provides stakeholder mapping and identifies four opportunity areas in the industry: Material Sience, Technology, Business Models and Regulations, Quality. It also provides industry road mapping and forecasting of the future of the industry.
The second white paper targets the opportunity area of business models, providing detailed descriptions of the barriers, analysing the root-causes of barriers and proposing solutions.
The project outcomes and white papers were officially presented to a diverse audience from academia and industry at one of our signature events, the Global Business Innovation Conversations: 3D printing: The medical device revolution, which took place on 4 Dec 2019 at Engineers Australia. You can watch the event video below:
This event provided state-of-the-art insights into the application of 3D printing in the Australian Medical device industry.
The project impact description, by chief investigator Sam Tavassoli.
Acknowledgement of country
RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business. - Artwork created by Louisa Bloomer